251 related articles for article (PubMed ID: 34560057)
1. Increase in diagnostic yield achieved for 174 whole-exome sequencing cases reanalyzed 1-2 years after initial analysis.
Liu Y; Teng Y; Li Z; Cui J; Liang D; Wu L
Clin Chim Acta; 2021 Dec; 523():163-168. PubMed ID: 34560057
[TBL] [Abstract][Full Text] [Related]
2. Reanalysis of whole-exome sequencing (WES) data of children with neurodevelopmental disorders in a standard patient care context.
van Slobbe M; van Haeringen A; Vissers LELM; Bijlsma EK; Rutten JW; Suerink M; Nibbeling EAR; Ruivenkamp CAL; Koene S
Eur J Pediatr; 2024 Jan; 183(1):345-355. PubMed ID: 37889289
[TBL] [Abstract][Full Text] [Related]
3. Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling.
Mørup SB; Nazaryan-Petersen L; Gabrielaite M; Reekie J; Marquart HV; Hartling HJ; Marvig RL; Katzenstein TL; Masmas TN; Lundgren J; Murray DD; Helleberg M; Borgwardt L
Front Immunol; 2022; 13():906328. PubMed ID: 35874679
[TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders.
Ewans LJ; Schofield D; Shrestha R; Zhu Y; Gayevskiy V; Ying K; Walsh C; Lee E; Kirk EP; Colley A; Ellaway C; Turner A; Mowat D; Worgan L; Freckmann ML; Lipke M; Sachdev R; Miller D; Field M; Dinger ME; Buckley MF; Cowley MJ; Roscioli T
Genet Med; 2018 Dec; 20(12):1564-1574. PubMed ID: 29595814
[TBL] [Abstract][Full Text] [Related]
5. Lessons learned from additional research analyses of unsolved clinical exome cases.
Eldomery MK; Coban-Akdemir Z; Harel T; Rosenfeld JA; Gambin T; Stray-Pedersen A; Küry S; Mercier S; Lessel D; Denecke J; Wiszniewski W; Penney S; Liu P; Bi W; Lalani SR; Schaaf CP; Wangler MF; Bacino CA; Lewis RA; Potocki L; Graham BH; Belmont JW; Scaglia F; Orange JS; Jhangiani SN; Chiang T; Doddapaneni H; Hu J; Muzny DM; Xia F; Beaudet AL; Boerwinkle E; Eng CM; Plon SE; Sutton VR; Gibbs RA; Posey JE; Yang Y; Lupski JR
Genome Med; 2017 Mar; 9(1):26. PubMed ID: 28327206
[TBL] [Abstract][Full Text] [Related]
6. The added value of WES reanalysis in the field of genetic diagnosis: lessons learned from 200 exomes in the Lebanese population.
Jalkh N; Corbani S; Haidar Z; Hamdan N; Farah E; Abou Ghoch J; Ghosn R; Salem N; Fawaz A; Djambas Khayat C; Rajab M; Mourani C; Moukarzel A; Rassi S; Gerbaka B; Mansour H; Baassiri M; Dagher R; Breich D; Mégarbané A; Desvignes JP; Delague V; Mehawej C; Chouery E
BMC Med Genomics; 2019 Jan; 12(1):11. PubMed ID: 30665423
[TBL] [Abstract][Full Text] [Related]
7. Germline CNV Detection through Whole-Exome Sequencing (WES) Data Analysis Enhances Resolution of Rare Genetic Diseases.
Tilemis FN; Marinakis NM; Veltra D; Svingou M; Kekou K; Mitrakos A; Tzetis M; Kosma K; Makrythanasis P; Traeger-Synodinos J; Sofocleous C
Genes (Basel); 2023 Jul; 14(7):. PubMed ID: 37510394
[TBL] [Abstract][Full Text] [Related]
8. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
[TBL] [Abstract][Full Text] [Related]
9. [Comparison study of whole exome sequencing and targeted panel sequencing in molecular diagnosis of inherited retinal dystrophies].
Liu XZ; Li YY; Yang LP
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 52(5):836-844. PubMed ID: 33047716
[TBL] [Abstract][Full Text] [Related]
10. Unique bioinformatic approach and comprehensive reanalysis improve diagnostic yield of clinical exomes.
Schmitz-Abe K; Li Q; Rosen SM; Nori N; Madden JA; Genetti CA; Wojcik MH; Ponnaluri S; Gubbels CS; Picker JD; O'Donnell-Luria AH; Yu TW; Bodamer O; Brownstein CA; Beggs AH; Agrawal PB
Eur J Hum Genet; 2019 Sep; 27(9):1398-1405. PubMed ID: 30979967
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of automated, streamlined, daily updated exome analysis in patients with neurodevelopmental delay.
Seo GH; Lee H; Lee J; Han H; Cho YK; Kim M; Choi Y; Choi J; Choi IH; Rhie S; Chae KY; Kim YM; Cheon CK; Kim SJ; Lee J; Kang E; Byeon JH; Yu HJ; Shin YL; Oh A; Kim WJ; Yum MS; Lee BH; Eun BL
Mol Med; 2022 Mar; 28(1):38. PubMed ID: 35346031
[TBL] [Abstract][Full Text] [Related]
12. Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis.
Ewans LJ; Minoche AE; Schofield D; Shrestha R; Puttick C; Zhu Y; Drew A; Gayevskiy V; Elakis G; Walsh C; Adès LC; Colley A; Ellaway C; Evans CA; Freckmann ML; Goodwin L; Hackett A; Kamien B; Kirk EP; Lipke M; Mowat D; Palmer E; Rajagopalan S; Ronan A; Sachdev R; Stevenson W; Turner A; Wilson M; Worgan L; Morel-Kopp MC; Field M; Buckley MF; Cowley MJ; Dinger ME; Roscioli T
Eur J Hum Genet; 2022 Oct; 30(10):1121-1131. PubMed ID: 35970915
[TBL] [Abstract][Full Text] [Related]
13. Detection of Disease-Causing SNVs/Indels and CNVs in Single Test Based on Whole Exome Sequencing: A Retrospective Case Study in Epileptic Encephalopathies.
Sun D; Liu Y; Cai W; Ma J; Ni K; Chen M; Wang C; Liu Y; Zhu Y; Liu Z; Zhu F
Front Pediatr; 2021; 9():635703. PubMed ID: 34055682
[No Abstract] [Full Text] [Related]
14. Effectiveness of Whole-Exome Sequencing for the Identification of Causal Mutations in Patients with Suspected Inherited Ocular Diseases.
Ordoñez-Labastida V; Montes-Almanza L; García-Martínez F; Zenteno JC
Rev Invest Clin; 2022; 74(4):219-226. PubMed ID: 36087940
[TBL] [Abstract][Full Text] [Related]
15. Increasing the diagnostic yield of exome sequencing by copy number variant analysis.
Marchuk DS; Crooks K; Strande N; Kaiser-Rogers K; Milko LV; Brandt A; Arreola A; Tilley CR; Bizon C; Vora NL; Wilhelmsen KC; Evans JP; Berg JS
PLoS One; 2018; 13(12):e0209185. PubMed ID: 30557390
[TBL] [Abstract][Full Text] [Related]
16. Exome sequencing as a first-tier test for copy number variant detection: retrospective evaluation and prospective screening in 2418 cases.
Testard Q; Vanhoye X; Yauy K; Naud ME; Vieville G; Rousseau F; Dauriat B; Marquet V; Bourthoumieu S; Geneviève D; Gatinois V; Wells C; Willems M; Coubes C; Pinson L; Dard R; Tessier A; Hervé B; Vialard F; Harzallah I; Touraine R; Cogné B; Deb W; Besnard T; Pichon O; Laudier B; Mesnard L; Doreille A; Busa T; Missirian C; Satre V; Coutton C; Celse T; Harbuz R; Raymond L; Taly JF; Thevenon J
J Med Genet; 2022 Dec; 59(12):1234-1240. PubMed ID: 36137615
[TBL] [Abstract][Full Text] [Related]
17. Reanalysis of whole exome sequencing data in patients with epilepsy and intellectual disability/mental retardation.
Li J; Gao K; Yan H; Xiangwei W; Liu N; Wang T; Xu H; Lin Z; Xie H; Wang J; Wu Y; Jiang Y
Gene; 2019 Jun; 700():168-175. PubMed ID: 30904718
[TBL] [Abstract][Full Text] [Related]
18. Re-analysis of whole-exome sequencing data uncovers novel diagnostic variants and improves molecular diagnostic yields for sudden death and idiopathic diseases.
Salfati EL; Spencer EG; Topol SE; Muse ED; Rueda M; Lucas JR; Wagner GN; Campman S; Topol EJ; Torkamani A
Genome Med; 2019 Dec; 11(1):83. PubMed ID: 31847883
[TBL] [Abstract][Full Text] [Related]
19. Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing.
Alfares A; Aloraini T; Subaie LA; Alissa A; Qudsi AA; Alahmad A; Mutairi FA; Alswaid A; Alothaim A; Eyaid W; Albalwi M; Alturki S; Alfadhel M
Genet Med; 2018 Nov; 20(11):1328-1333. PubMed ID: 29565419
[TBL] [Abstract][Full Text] [Related]
20. Molecular findings in patients for whole exome sequencing and mitochondrial genome assessment.
Sun G; Huang W; Wang L; Wu J; Zhao G; Ren H; Liu L; Kong X
Clin Chim Acta; 2024 Jun; 561():119774. PubMed ID: 38852791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
